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Background: Smoking is a growing concern among young women. However, the pulmonary ef-
fects of smoking in young female smokers in their 20’s are unknown.
Objective: The purpose of this study was to determine whether young female smokers demon-
strate smoking-related lung abnormalities such as bronchiolitis in their 20’s.
Methods: We recruited young females (20e30 yr) from Izmir, Turkey; 29 smokers and 31 life-
time non-smokers. They were all asymptomatic. All subjects performed complete lung func-
tion measurements and underwent thoracic computed tomography (CT) scanning at
suspended full inspiration using a Toshiba “Aquilion” multi-slice CT scanner. The CT images
were analyzed using custom software (Emphylx-J) and published equations to calculate total
lung volume, mean lung density, lung mass, and the extent of emphysema. CT images were
also read semi-quantitatively for respiratory bronchiolitis and emphysema by 2 experienced
chest radiologists. When there was substantial difference in scoring, a 3rd (independent) radi-
ologist read the CT scans. Plasma biomarkers of smoking were also measured in these subjects.
Results: Although none of the subjects demonstrated emphysema on CT images, 41% of
smokers (compared with only 15% of non-smokers) had evidence for respiratory bronchiolitis
(with a score of 2 or more; p Z 0.0301). There was a significant relationship between pack-
years of smoking and the severity of respiratory bronchiolitis in smokers. Plasma interleukinspital, 1081 Burrard Street, Vancouver, British Columbia V6Z 1Y6, Canada. Tel.: þ1 604 806 8395; fax:
(D.D. Sin).
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Bronchiolitis in young female smokers 733(IL)-6 levels were also higher in smokers than in non-smokers (pZ 0.028). Quantitative analysis
for emphysema or airways disease on CT scans did not reveal any significant differences in the
two groups with the exception of lung mass, which was higher in the smokers than in non-
smokers. Lung function was similar between the two groups.
Conclusion and clinical relevance: Young female smokers in their 20’s and 30’s demonstrate CT
changes consistent with respiratory bronchiolitis and elevated plasma IL-6 levels. They also
have “heavier” lungs compared with lifetime non-smokers. These data indicate that pathologic
changes of smoking occur early in young female smokers in the absence of demonstrable air-
flow limitation or symptoms. Public health efforts to curb smoking in young women are clearly
needed to reduce the burden of smoking related lung disease in women.
ª 2013 Elsevier Ltd. All rights reserved.Introduction
There is a global epidemic of smoking-related lung dis-
eases. Worldwide, smoking is responsible for nearly 5 mil-
lion deaths annually.1 In the Western World, the rates of
chronic obstructive pulmonary disease (COPD) are increas-
ing at a much faster rate in women than in men.2 Alarm-
ingly, women who smoke 20 cigarettes per day (i.e. 1 pack/
day) are 60 times more likely to develop COPD than non-
smoking females.3 However, despite this information
young people, especially women, continue to smoke at an
alarming rate and most start to smoke in their teens or
early 20’s. In the US, for instance, the age group with the
highest percentage of female smokers is between 20 and 30
years of age.4 In this age group, many female smokers
believe that they can stop smoking at a later age and avoid
the adverse impact of cigarette smoke or that smoking
modestly has no significant impact on health.5 It is not
known however whether smoking produces any demon-
strable adverse effects in the lungs of young female
smokers. In the early 1970’s using data from resected lung
tissue, Niewoehner and colleagues showed that the earliest
pathologic feature of cigarette smoking in lungs of young
male smokers was respiratory bronchiolitis, which could be
detected by histology, decades before the development of
other pathologic features of smoking-related lung disease
such as emphysema and airway wall remodeling.6 However,
because lung function measurements were not performed
in this cohort, it is not known whether the smoking-related
bronchiolitis resulted in any demonstrable airflow limita-
tion. Furthermore, Niewoehner’s study included only heavy
male smokers (average age: 25 years and average smoking
history of 20 pack-years). Thus, the findings of this study
may not be generalizable to young female smokers, who on
average smoke fewer cigarettes per day (than their male
counterparts) and have increased risk of bronchial hyper-
responsiveness.7 With the advent of multi-detector com-
puted tomography (MDCT) and high spatial resolution al-
gorithms, it is possible to detect early changes of smoking
related lung injury that could only be diagnosed using
invasive methods or in ex vivo lungs. The primary purpose
of this study was to determine the effects of cigarette
smoking in the lungs of young female smokers in their 20’s.
We hypothesized that very early signs of emphysema and/
or small airways disease can be measured using quantita-
tive CT in young women. To study this question we
recruited young women, both smokers and lifetime non-
smokers and compared their pulmonary function datawith both quantitative analysis of CT scans and a visual
assessment of the images.
Methods
Study participants
Young female volunteers, aged between 20 and 30 years
were recruited in Izmir, Turkey through advertising on
bulletin boards around university campus and nurses’ dor-
mitory (Ege University, Izmir, Turkey). Thus, all partici-
pants in this study were either university students or nurses
employed at the university hospital. One group consisted of
active smokers with at least 5 pack-years of smoking his-
tory (smoking group) and the other consisted of lifetime
non-smokers (control group). To qualify for the study, the
subjects had to be free of any significant respiratory
symptoms (such as cough or dyspnea), did not have any
pulmonary disorders (e.g. asthma, COPD, bronchiectasis or
tuberculosis) or co-morbidities (e.g. diabetes, car-
diovascular disorder), were not taking any prescription
medications and were not part of any other research study.
All participants provided written informed consent and the
study was approved by the Research Ethics Board of Ege
University.
Procedures
Following informed consent, the subjects underwent full
lung function measurements using Sensormedics Vmax
Spectra 22D spirometer in accordance with the recom-
mendations of ATS/ERS8 and thoracic computed tomogra-
phy (CT) scanning. All CT images were obtained at full
inspiration without the use of intravenous contrast media,
using a Toshiba Aquilion 16 slice multi-detector row CT
scanner (Toshiba Medial Systems, Tokyo Japan) and the
following parameters: 120 kVp, 40 mAs and the images
were reconstructed using contiguous 1 mm thick images
(FC51 reconstruction kernel) and contiguous 5 mm thick
images (FC11 reconstruction kernel). On the day of pul-
monary function tests and CT imaging, blood samples were
drawn from all participants for analysis of interleukin (IL)-6
and surfactant protein-D (SP-D) measurements using com-
mercial assay kits (R and D Systems for IL-6 and Biovendor
for SP-D) and methods previously described.9 These pro-
teins were chosen a priori because plasma IL-6 levels are
strongly associated with adverse health outcomes in
Figure 1 Representative MDCT images of respiratory bron-
chiolitis. (a) Shows control (no bronchiolitis). (b) Shows RB
score of 1. (c) Shows RB score of 2 or more.
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ciated with increased lung permeability.11
Qualitative image analysis
The 1 mm thick images were subjectively assessed by two
thoracic radiologists, who were blinded to the group
assignment of the participants, to determine the extent of
emphysema and the burden of bronchiolitis. A third reader
provided consensus in the setting of discordance. Emphy-
sema was scored using a previously described scoring sys-
tem as follows: none (0), trivial (1) mild (2), moderate (3),
severe (4), or very severe (5). Bronchiolitis was scored using
a quartile system according to Fleischner guidelines and the
following scale: none (0), trivial (1), mild/moderate (2), or
moderate/severe (3). Bronchiolitis was defined as cen-
trilobular micronodules and patchy ground-glass opacity
using Fleischner Glossary of terms.12 The weighted kappa
statistics for agreement of the bronchiolitis score was 0.842
(95% confidence interval, CI, 0.611e1.000). Centrilobular
nodules were separated by several millimeters from the
pleural surfaces, fissures, and interlobular septa and may
be of soft-tissue or ground-glass attenuation (Fig. 1).
Quantitative image analysis
Quantitative analysis was performed in two steps using cus-
tom software (EmphylxJ, University of British Columbia,
flintbox.com) as previously described.13 First, emphysema
was assessed using the 5 mm, low spatial frequency recon-
structed CT images (FC11) by segmenting the lung paren-
chyma from the chest wall and large central blood vessels
and by using amodified border-tracing algorithmwith a prior
position-knowledge algorithm. The segmented pixel area in
each slice was summed and multiplied by the slice thickness
to acquire the total lung volume. ThemeanCTattenuation of
the lung in Hounsfield units (HU) was calculated and con-
verted to a measure of density in g/ml by adding 1000 to the
HU number and dividing by 1000. The mean density of the
lung was thenmultiplied by the lung volume to estimate lung
mass. The extent of emphysema, or low attenuation area
(LAA), was defined as voxels with an attenuation value less
than 950 HU and expressed as percent of the total lung
volume. The apparent X-ray attenuation value at the lowest
15th percentile point of the distribution was also calculated.
A “lowattenuation cluster analysis”was used toestimate the
size distribution of the low density regions within the lung.
The inverse slope of the logelog relationship of the size of
the clusters (number of contiguous voxels less than950 HU)
versus the number of clusters of that size is the power-law
exponent (D). Individuals with diffuse small clusters of low
density lung will have a steeper slope (i.e. greater D) than
individuals with larger-sized low density regions.
Second, cross sectional airway dimensions were deter-
mined using the full-width at half maximum algorithm as
previously described. Briefly, using the thin slice (1 mm) high
spatial frequency reconstruction CT images (FC51) a random
imagewas selected near the apex of the lung. From this start
point, every 10th imagewas chosen and all airways thatwere
cut in a reasonable cross section (long/short internal diam-
eter 2.2 or less) were identified. Every 10th image waschosen to sample unique airways and on average 23  12
airways per subject were measured (minimum Z 4,
maximumZ 55). A seed point was placed in the lumen of the
airway and the internal and external boundary of the airway
wall were determined by casting radial lines from this seed
point and finding the internal and external point at which the
X-ray attenuation value along the line was half themaximum
value within the wall. A standardized measurement of air-
way wall thickness was obtained to try to minimize sampling
bias. The measurements of internal perimeter (Pi) were
correlated with the square root of airway wall area (Aaw) for
Bronchiolitis in young female smokers 735each subject individually. Using the resulting regression
equation square root of the airway wall for an idealized
airway with an internal perimeter of 10 mm (AWT-Pi10) for
each subject was calculated.
Statistical analysis
Continuous variables between the smokers and controls
were compared using a Student t test. For non-normally
distributed variables (e.g. plasma IL-6 levels), a logarith-
mic distribution was used to transform the variables.
Dichotomous variables were compared using a chi-square
test with appropriate degrees of freedom. A two-tailed p-
value less than 0.05 was considered significant. Based on
a previous study, we estimated the SD of the bronchiolitis
score to be 0.26.14 With a sample size of 25 (in each group),
we had >80% power to detect a mean difference score of
0.213 or greater between the smokers and non-smokers
with respect to the bronchiolitis score. All analyses were
performed using SAS version 9.2 (Carey, N.C.)
Results
There were 60 subjects in the study. Their mean age was
24.4  3.1 (mean  SD) years and mean body mass index
(BMI) was 21.5  3.3 kg/m2. The clinical characteristics of
the study participants according to their smoking status are
summarized in Table 1. There was good balance in the
baseline characteristics between the two groups except forTable 1 Clinical characteristics of smokers and non-
smokers.
Variables Non-smokers
(n Z 31)
Smokers
(n Z 29)
P
Age (years) 23.8  2.63 24.9  3.5 0.186
BMI (kg/m2) 20.6  2.8 22.5  2.9 0.023
Smoking
history
(pack-years)
e 8.1  4.4 e
Age at
smoking
initiation
e 16.8  2.8 e
FEV1 (% of
reference
value)
92.4  13.2 94.4  11.1 0.526
FEV1 (ml) 3079  486 3099  385 0.861
FVC (% of
reference
value)
93.4  14.0 96.3  11.8 0.382
FVC (ml) 3605  607 3673  472 0.628
FEV1/FVC (%) 86.7  5.7 84.7  6.7 0.221
DLCO (% of
reference
value)
84.0  15.5 84.1  12.4 0.985
BMI Z body mass index.
DLCO Z diffusing capacity of the lung for carbon monoxide.
FEV1 Z forced expiratory volume in one second.
FVC Z forced vital capacity.BMI, which was larger in the smoking group compared to the
control group (p Z 0.023). Specifically, there were no sig-
nificant differences in the lung function parameters be-
tween the two groups. No subjects had forced expiratory
volume in one second (FEV1) to forced vital capacity (FVC)
ratio less than 0.7, indicating significant airflow limitation.
There was no emphysema visually apparent in any of the
subjects. However, there were significant differences in the
mean bronchiolitis score between the two groups
(p Z 0.019). Twelve (41%) of the smokers group had bron-
chiolitis score of 2 or greater compared to only 5 (16%) in the
control group (Fig. 2; pZ 0.0301). In the smokers group, 15
(52%) of the subjects did not have any radiographic evidence
of bronchiolitis, while in the control group 26 (84%) did not
have bronchiolitis. There was a significant relationship be-
tween the respiratory bronchiolitis score and pack-years of
smoking history with an increment of 10 pack-years leading
to 0.7 unit rise in the respiratory bronchiolitis score
(pZ 0.0296). Fig. 3 demonstrates the relationship between
pack-years of smoking and the respiratory bronchiolitis
score.
Although the quantitative analysis did not reveal any
significant differences in lung volume, density or extent
emphysema, measured using either the threshold analysis
(%LAA) or the lowest 15th percentile value between the two
groups, the calculated lung mass of the smokers was sig-
nificantly greater than that in the control group. Moreover,
using a low attenuation cluster analysis, smokers demon-
strated increased D values suggesting less heterogeneity in
the size of airspaces. There were no significant differences
in any of the airway wall measurements.
Plasma IL-6 levels were increased in the smokers’ group
than in the control group (Fig. 3; p Z 0.028). Plasma SP-D
levels, however, did not differ significantly between the
two groups (p Z 0.259) (see Table 2). Neither plasma IL-6
(Spearman rho Z 0.23; p Z 0.138) nor SP-D levels (Spear-
man rho Z 0.05; p Z 0.740) were significantly related to
the bronchiolitis score.Figure 2 The relationship of smoking status to the occur-
rence and severity of bronchiolitis detected on MDCT. P values
determined using a chi-square test.
Figure 3 The relationship of the respiratory bronchiolitis
score to pack-years of smoking.
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The most important finding of the present study was that
young female smokers in their 20’s have radiographic evi-
dence of small airway disease (i.e. bronchiolitis), “heavier”Table 2 Radiographic findings in young female
participants.
Variables Non-smokers Smokers P
Total lung
volume (L)
4123  791 4246  757 0.481
Total lung
mass (g)
535 ± 91 592 ± 110 0.032
Mean lung
density
(g/mL)
0.134  0.030 0.144  0.034 0.333
D (-950) 1.91 ± 0.44 2.14 ± 0.43 0.016
Low attenuation
area (%)b
12.2  15.1 9.1  15.1 0.446
15% percentile
cutoff (HU)
984  30 972  35 0.284
Pi10 (mm) 2.68  0.36 2.72  0.34 0.846
RB score 0.355  0.829 1.035  1.172 0.019
IL-6 (pg/ml)a 1.54  0.655 2.22  0.458 0.028
SP-D (ng/ml)a 55.6  0.763 72.1  0.998 0.259
HU Z Houndsfield unit.
RB Z Respiratory Bronchiolitis.
IL-6 Z interleukin-6.
SP-D Z surfactant protein D.
D Z inverse slope of the logelog relationship of the size of the
clusters (number of contiguous voxels that are inflated beyond
the predicted value for maximum lung inflation for that indi-
vidual) versus the number of clusters of that size is the power-
law exponent.
Significant row comparisons have been bolded.
a Results reported as geometric mean  coefficient of
variation.
b Percentage of the lungs with a density less than 950
Hounsfield Units.lungs and elevated plasma IL-6 levels compared to similar
aged non-smoking women. Importantly, none of the smok-
ing women had radiographic evidence of emphysema.
Together, these data suggest smoking related changes are
first notable in the airways (and not in the parenchyma),
occur very early in life and that they can be detected using
MDCT. We also found that none of the female smokers had
developed airflow limitation on spirometry. These data
suggest that in young smokers spirometry is insensitive (and
unlikely to be clinically useful) in detecting smoking-
related lung changes. Whether plasma biomarkers such as
IL-6 would be useful in this setting is uncertain.
Our study findings are consistent with those of Nie-
woehner and colleagues who demonstrated in 39 young
men (mean age 25 years and 20 mean pack-years of
smoking) that the most consistent pathologic finding among
smokers was respiratory bronchiolitis.6 Indeed, in this
study, all 19 young male smokers had histologic evidence of
respiratory bronchiolitis but only 5 out of 20 non-smokers
demonstrated this feature. However, no women were
included in this study and all the subjects were heavy
smokers with an average smoking history of 25  7 pack-
years (mean  SD). Thus, we extend the findings of Nie-
woehner et al. by demonstrating radiographic evidence of
respiratory bronchiolitis in young female smokers who had
on average only 8  4 pack-years of smoking.
There were no large quantitative differences in CT
density between the two groups of subjects. However,
smokers demonstrated “heavier” lungs, which is in line with
other published studies that have shown significant changes
in lung density before and following smoking cessation.
Investigators in Copenhagen, for instance, have reported
that there is a rapid decrease in lung density, assessed using
the lowest 15th percentile, following smoking cessation and
a similar decline in subjects receiving inhaled corticoste-
roids.15,16 These authors suggested that a change in the
inflammatory response may have been responsible for these
small but significant changes in lung density. We were not
able to demonstrate a difference in the lung density at the
lowest 15th percentile point, and this may be due to the
fact that these women were young and most of their lung
density fell within the normal range. However, there was
a trend for an increased mean lung density which did reach
significance when combined with the lung volume to cal-
culate lung mass.
Given the location of the airway lesions (in the small
airways), it is not surprising that none of the subjects in our
study demonstrated airflow limitation. Small airways are
often referred to as the “quiet zone”, which because of its
large surface area can become extensively diseased and
still not lead to symptoms or significant airflow limitation.17
Although in the present study, we did not re-image the
subjects following smoking cessation, previous studies
suggest that the small airway changes related to cigarette
smoking are partially reversible in about two-third of
smokers. Similarly, smoking cessation appears to reduce
plasma IL-6 levels.18
There were some limitations to the present study. First,
this was a cross-sectional study. As such, the natural history
of the small airway changes related to cigarette smoke is
unknown. However, previous studies suggest that over
time, permanent remodeling takes place in the small
Bronchiolitis in young female smokers 737airways, leading to significant airflow limitation and symp-
toms.19,20 Second, owing to the study design, we cannot
fully assign causality. However, a recent study by McDo-
nough et al. suggests that the pathological process in
chronic obstructive pulmonary disease (COPD) begins in the
small airways and spreads distally into lung parenchyma,
causing tissue destruction and emphysematous changes.21
Third, we did not have histological verification of the CT
findings. Thus, we cannot be absolutely certain that the CT
based diagnosis of respiratory bronchiolitis was indeed
true. However, previous studies have shown excellent cor-
relation between CT and histologic findings of respiratory
bronchiolitis,22,23 providing some reassurances.
In summary, the present study indicates that young fe-
male smokers with a very modest smoking history demon-
strate CT findings consistent with respiratory bronchiolitis
and systemic inflammation in the absence of any lung
function changes. These data indicate that the adverse
effects of smoking occur at a very young age in women and
highlight the importance of early intervention and educa-
tion to reduce global smoking rates in young women.
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